Finegold Sm
- Clinical Biochemistry top 5%
- Bacterial Identification and Susceptibility Testing 13
- Endocrinology top 10%
- Diphtheria, Corynebacterium, and Tetanus 3
-
- Antibiotic Use and Resistance 3
- Molecular Medicine top 10%
- Infectious Diseases top 10%
- Clostridium difficile and Clostridium perfringens research 5
- Antimicrobial Resistance in Staphylococcus 3
-
- Orthopedic Infections and Treatments 4
-
- Antibiotics Pharmacokinetics and Efficacy 4
-
- Streptococcal Infections and Treatments 3
- Co-authors
- Irwin ZimentMartin WjItzhak BrookAlison F. DavisAmanda K. DavisJacobo SabbajBartlett JgA. Davis
- Journals
- PubMed (42 papers)
- Partner nations
- United States
In The Last Decade
Finegold Sm
37 papers receiving 344 citations
Peers
Comparison fields: 5 of 74
- Clinical Biochemistry 104
- Endocrinology 63
- Applied Microbiology and Biotechnology 24
- Molecular Medicine 48
- Infectious Diseases 121
Countries citing papers authored by Finegold Sm
This map shows the geographic impact of Finegold Sm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Finegold Sm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Finegold Sm more than expected).
Fields of papers citing papers by Finegold Sm
This network shows the impact of papers produced by Finegold Sm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Finegold Sm. The network helps show where Finegold Sm may publish in the future.
Co-authorship network
The 14 scholars most cited alongside Finegold Sm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Serum penicillin concentration following oral administration of penicillin V. | 2002 | 0 |
| 2 | Ticarcillin/clavulanate versus imipenem/cilistatin for the treatment of infections associated with gangrenous and perforated appendicitis. | 1999 | 17 |
| 3 | [A laboratory and clinical trial of the combined preparation ampicillin/sulbactam]. | 1991 | 1 |
| 4 | Media- and method-dependent variation in MIC values of ceftizoxime for clinical isolates of the Bacteroides fragilis group. | 1991 | 3 |
| 5 | Effect of inoculum size and medium on activity of seven antimicrobial agents against Bacteroides fragilis strains. | 1990 | 5 |
| 6 | Normal human intestinal flora. | 1986 | 12 |
| 7 | A prospective double-blind comparison of piperacillin, cephalothin and cefoxitin in the prevention of postoperative infections in patients undergoing intra-abdominal operations. | 1985 | 7 |
| 8 | The effect of antimicrobial agents on human faecal flora: studies with cephalexin, cyclacillin and clindamycin. | 1974 | 39 |
| 9 | The significance of the intestinal microflora. | 1970 | 3 |
| 10 | Clinical features and diagnosis of anaerobic pleuropulmonary infections. | 1970 | 6 |
| 11 | Infections due to non-sporeforming anaerobic bacteria. | 1970 | 3 |
| 12 | Urease and deaminase activities of fecal bacteria in hepatic coma. | 1970 | 15 |
| 13 | Photomicrography of bacterial colonies in rool tubes. | 1969 | 1 |
| 14 | Infections due to anaerobes. | 1968 | 16 |
| 15 | Evaluation of polyanethol sulfonate (liquoid) in blood cultures. | 1967 | 19 |
| 16 | Nalidixic acid: clinical and laboratory studies. | 1966 | 11 |
| 17 | Operations on the colon. The role of antibiotics in preoperative preparation. | 1965 | 3 |
| 18 | NEUTROPENIC REACTION TO CEPHALOTHIN THERAPY. | 1963 | 26 |
| 19 | DIPHTHEROID ENDOCARDITIS AFTER CARDIOPULMONARY BYPASS SURGERY FOR THE REPAIR OF CARDIAC VALVULAR DEFECTS. | 1963 | 32 |
| 20 | CONTROLLED EVALUATION OF ENVIRONMENTAL DECONTAMINATION OF GENERAL SURGICAL WARDS. | 1963 | 3 |
About Finegold Sm
Finegold Sm is a scholar working on Clinical Biochemistry, Applied Microbiology and Biotechnology and Molecular Medicine, having authored 42 papers that have together received 439 indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (13 papers), Clostridium difficile and Clostridium perfringens research (5 papers), Orthopedic Infections and Treatments (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Antimicrobial Resistance in Staphylococcus (3 papers), Streptococcal Infections and Treatments (3 papers), Diphtheria, Corynebacterium, and Tetanus (3 papers) and Antibiotic Use and Resistance (3 papers). The work is most often cited by research in Clinical Biochemistry (104 citations), Endocrinology (63 citations) and Applied Microbiology and Biotechnology (24 citations). Finegold Sm has collaborated with scholars based in United States. Frequent co-authors include Irwin Ziment, Martin Wj, Itzhak Brook, Alison F. Davis, Amanda K. Davis, Jacobo Sabbaj, Bartlett Jg, A. Davis, Krishna Kathir and M.A. Lentz. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.